Extended-release methylphenidate monotherapy in patients with comorbid social anxiety disorder and adult attention-deficit/hyperactivity disorder: retrospective case series

KOYUNCU A., Celebi F., Ertekin E., Kok B. E., Tukel R.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY, cilt.7, sa.11, ss.241-247, 2017 (SCI-Expanded) identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 7 Sayı: 11
  • Basım Tarihi: 2017
  • Doi Numarası: 10.1177/2045125317714193
  • Dergi Adı: THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), EMBASE, Directory of Open Access Journals
  • Sayfa Sayıları: ss.241-247
  • Anahtar Kelimeler: attention-deficit/hyperactivity disorder, comorbidity, extended-release methylphenidate, social anxiety disorder, treatment, DEFICIT HYPERACTIVITY DISORDER, AGE-DEPENDENT DECLINE, PSYCHIATRIC COMORBIDITY, ATOMOXETINE TREATMENT, CONTROLLED-TRIAL, ADHD, CHILDREN, PREVALENCE, PHOBIA, PREDICTORS
  • İstanbul Üniversitesi Adresli: Evet

Özet

Background: The relationship between social anxiety disorder (SAD) and attention-deficit/hyperactivity disorder (ADHD) is a subject which has recently become a topic of interest for research.